ResearcherJiangsu Province HospitalActive in the last 2 years
Shangnan Dai
Matched on ORCID iD 0009-0009-4006-0140; OpenAlex author ID A5048768620. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 8
- Single-cell spatial transcriptional profiling of pancreatic ductal adenocarcinoma uncovers key immune-modulating and pro-metastatic mechanisms. Co-author DOI 10.1016/j.canlet.2026.218613↗
- LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-024-01358-7↗
- USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. First author DOI 10.1038/s41418-024-01426-y↗
- High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. Co-author DOI 10.1007/s10495-023-01901-w↗
- Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer. Co-author DOI 10.1002/mc.23627↗
- Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. First author DOI 10.3389/fcell.2021.714718↗
- Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. Co-author DOI 10.1016/j.biopha.2019.109521↗
- EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. First author DOI 10.1016/j.biopha.2020.109972↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yi Miao · 5 shared papers, 2020–2025 · strength 0.78
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Zipeng Lu · 4 shared papers, 2021–2025 · strength 0.78
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Lingdi Yin · 4 shared papers, 2021–2025 · strength 0.78
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Guangfu Wang · 4 shared papers, 2021–2025 · strength 0.78
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Kuirong Jiang · 3 shared papers, 2025–2026 · strength 0.69
- Paper Single-cell spatial transcriptional profiling of pancreatic ductal adenocarcinoma uncovers key immune-modulating and pr… DOI 10.1016/j.canlet.2026.218613↗
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Qiuyang Chen · 3 shared papers, 2020–2025 · strength 0.49
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer. DOI 10.1002/mc.23627↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521↗
- Junli Wu · 3 shared papers, 2020–2025 · strength 0.43
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521↗
- Yi Miao · 2 shared papers, 2023–2024 · strength 0.40
- Yunpeng Peng · 2 shared papers, 2020–2025 · strength 0.31
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521↗
- Jing Zhou · 1 shared paper, 2026 · strength 0.26
- Yefan Yang · 1 shared paper, 2026 · strength 0.26
- Dalai Xu · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521↗
- Feng Zhu · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521↗
- Kai Zhang · 1 shared paper, 2025 · strength 0.22
- Kuirong Jiang · 1 shared paper, 2024 · strength 0.22
- Jishu Wei · 1 shared paper, 2025 · strength 0.21
- Min Tu · 1 shared paper, 2025 · strength 0.21
- Yue Fu · 1 shared paper, 2023 · strength 0.18
- Xinchun Liu · 1 shared paper, 2023 · strength 0.18
- Peng Wang · 1 shared paper, 2023 · strength 0.18
- Xumin Huang · 1 shared paper, 2021 · strength 0.13
- Hao Gao Gao · 1 shared paper, 2021 · strength 0.13
- Xiaole Zhu · 1 shared paper, 2020 · strength 0.10
- Yi Zhu · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.